Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates

P. Zak, E. Vejrazkova, A. Zavrelova, L. Pliskova, L. Ryskova, P. Hubacek, V. Stepanova, M. Kostal, V. Koblizek, P. Paterova, J. Radocha,

. 2020 ; 65 (1) : 109-120. [pub] 20190509

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20024244

Grantová podpora
PROGRES Q40/08 PROGRES Q40/08
grant no. 17-28539A grant no. 17-28539A
MH CZ - DRO (UHHK, 00179906) MH CZ - DRO (UHHK, 00179906)
NV17-28539A MZ0 CEP - Centrální evidence projektů

The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies over a period of 7 years. The results of culture methods, PCR, and immunoenzymatic sandwich microplate assays for Aspergillus galactomannan (GM) in BALF were analyzed. Further, the diagnostic thresholds for Aspergillus GM and Pneumocystis jiroveci were also calculated. Microbiological findings were present in 87% of BALF samples. Possible infectious pathogens were detected in 55% of cases; 32% were classified as colonizing. No significant difference in diagnostic yield or pathogen spectrum was found between non-neutropenic and neutropenic patients. There was one significant difference in BALF findings among intensive care units (ICU) versus non-ICU patients for Aspergillus spp. (22% versus 9%, p = 0.03). The most common pathogens were Aspergillus spp. (n = 86, 33% of BAL with causative pathogens) and Streptococcus pneumoniae (n = 46, 18%); polymicrobial etiology was documented in 20% of cases. A quantitative PCR value of > 1860 cp/mL for Pneumocystis jirovecii was set as a diagnostic threshold for pneumocystis pneumonia. The absorbance index of GM in BALF of 0.5 was set as a diagnostic threshold for aspergillosis. The examination of BAL fluid revealed the presence of pathogen in more than 50% of cases and is, therefore, highly useful in this regard when concerning pulmonary infiltrates.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20024244
003      
CZ-PrNML
005      
20201208102222.0
007      
ta
008      
201208s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-019-00712-4 $2 doi
035    __
$a (PubMed)31073843
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zak, P $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic.
245    10
$a BAL fluid analysis in the identification of infectious agents in patients with hematological malignancies and pulmonary infiltrates / $c P. Zak, E. Vejrazkova, A. Zavrelova, L. Pliskova, L. Ryskova, P. Hubacek, V. Stepanova, M. Kostal, V. Koblizek, P. Paterova, J. Radocha,
520    9_
$a The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.) An analysis of 480 BALF samples was performed in patients with hematological malignancies over a period of 7 years. The results of culture methods, PCR, and immunoenzymatic sandwich microplate assays for Aspergillus galactomannan (GM) in BALF were analyzed. Further, the diagnostic thresholds for Aspergillus GM and Pneumocystis jiroveci were also calculated. Microbiological findings were present in 87% of BALF samples. Possible infectious pathogens were detected in 55% of cases; 32% were classified as colonizing. No significant difference in diagnostic yield or pathogen spectrum was found between non-neutropenic and neutropenic patients. There was one significant difference in BALF findings among intensive care units (ICU) versus non-ICU patients for Aspergillus spp. (22% versus 9%, p = 0.03). The most common pathogens were Aspergillus spp. (n = 86, 33% of BAL with causative pathogens) and Streptococcus pneumoniae (n = 46, 18%); polymicrobial etiology was documented in 20% of cases. A quantitative PCR value of > 1860 cp/mL for Pneumocystis jirovecii was set as a diagnostic threshold for pneumocystis pneumonia. The absorbance index of GM in BALF of 0.5 was set as a diagnostic threshold for aspergillosis. The examination of BAL fluid revealed the presence of pathogen in more than 50% of cases and is, therefore, highly useful in this regard when concerning pulmonary infiltrates.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a Aspergillus $x genetika $x izolace a purifikace $x patogenita $7 D001230
650    _2
$a bronchoalveolární lavážní tekutina $x mikrobiologie $7 D001992
650    _2
$a DNA fungální $x genetika $7 D004271
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hematologické nádory $x komplikace $x mikrobiologie $7 D019337
650    _2
$a lidé $7 D006801
650    _2
$a jednotky intenzivní péče $7 D007362
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mannany $x analýza $7 D008351
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neutropenie $x mikrobiologie $7 D009503
650    _2
$a Pneumocystis carinii $x genetika $x izolace a purifikace $x patogenita $7 D045363
650    _2
$a pneumocystová pneumonie $x diagnóza $x mikrobiologie $7 D011020
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a Streptococcus pneumoniae $x genetika $x izolace a purifikace $x patogenita $7 D013296
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vejrazkova, E $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic.
700    1_
$a Zavrelova, A $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic.
700    1_
$a Pliskova, L $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic.
700    1_
$a Ryskova, L $u Institute of Clinical Microbiology of University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic.
700    1_
$a Hubacek, P $u Department of Medical Microbiology of 2nd Medical Faculty of Charles University and Motol University Hospital, Charles University, Prague, Czech Republic.
700    1_
$a Stepanova, V $u Institute of Clinical Microbiology of University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic.
700    1_
$a Kostal, M $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic.
700    1_
$a Koblizek, V $u Department of Pneumology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic.
700    1_
$a Paterova, P $u Institute of Clinical Microbiology of University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic.
700    1_
$a Radocha, Jakub $u 4th Department of Internal Medicine - Hematology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czech Republic. jakub.radocha@centrum.cz.
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 65, č. 1 (2020), s. 109-120
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31073843 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20201208 $b ABA008
991    __
$a 20201208102218 $b ABA008
999    __
$a ok $b bmc $g 1593199 $s 1114925
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 65 $c 1 $d 109-120 $e 20190509 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
GRA    __
$a PROGRES Q40/08 $p PROGRES Q40/08
GRA    __
$a grant no. 17-28539A $p grant no. 17-28539A
GRA    __
$a MH CZ - DRO (UHHK, 00179906) $p MH CZ - DRO (UHHK, 00179906)
GRA    __
$a NV17-28539A $p MZ0
LZP    __
$a Pubmed-20201208

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...